Dipen J Parekh
 | This biographical article is written like a résumé. (August 2024) |
 | This article may have been created or edited in return for undisclosed payments, a violation of Wikipedia's terms of use. It may require cleanup to comply with Wikipedia's content policies, particularly neutral point of view. (October 2019) |
Dipen J Parekh | |
|---|---|
| Born | 1969 Mumbai, India |
| Nationality | American |
| Alma mater | Vanderbilt University University of Poona Memorial Sloan Kettering Cancer Center |
| Known for | Robotic surgery in Urologic-Oncology |
| Scientific career | |
| Fields | Urologic-Oncology |
| Institutions | Miller School of Medicine University of Miami |
| Website | https://doctors.umiamihealth.org/provider/Dipen+J+Parekh/525779 |
Dipen J. Parekh (born in Mumbai, India) is Chief Operating Officer at the University of Miami Health System, Chairman of Urology and the Dr. Victor Politano Endowed Chair in Clinical Urology at the Miller School of Medicine at University of Miami in Miami.[1] He also serves as the Director of Robotic surgery at the University of Miami Health System.[2]
In 2013, he was awarded the American Urological Association Gold Cystoscope Award for his excellence in "establishing programs in urologic oncology and robotic surgery and outstanding contributions in transformative research".[3]
Personal life
[edit]A native of Gujarat, India Parekh completed his MBBS at University of Poona, graduating in 1991. He underwent post graduate training in General Surgery (1995) and super-specialized in Urology (1998) from the University of Mumbai. He completed his residency (2004) in urology from Vanderbilt University Medical Center and a fellowship (2006) at Memorial Sloan-Kettering Cancer Center in New York City. He also has a Masters in Healthcare Administration (2012) from Trinity University, Texas.[4]
Robotic surgery
[edit]He served as the Doctors Hospital at Renaissance Distinguished University Chair in Urology and Chief of Robotic Surgery and Urologic Oncology at the University of Texas Health Science Center in San Antonio from 2007 to 2012.[5]
In 2018, Parekh published the results of a clinical trial comparing Robotic Cystectomy vs. Open Cystectomy (RAZOR) in the medical journal The Lancet.[6] The RAZOR trial provided high evidence that robotic surgery is non-inferior to traditional surgery for bladder cancer.[7]
Other contributions
[edit]When performing partial nephrectomy, many surgeons clamp the renal artery. Urologic dogma has been that every minute of clamp time is detrimental to long-term kidney function. Therefore, Parekh led a study investigating this by performing biopsies on clamped kidneys and found no significant long-term effects with up to 60 minutes of ischemia.[8]
References
[edit]- ^ "Robotic Surgeon and Oncologist Dipen J. Parekh, M.D., Named Chair of Urology | Miller School of Medicine | University of Miami". med.miami.edu. University of Miami. Retrieved 6 October 2019.
- ^ "Dr. Dipen J. Parekh Named Chief Clinical Officer of University of Miami Health System | Miller School of Medicine | University of Miami". med.miami.edu.
- ^ "Previous Honorees - American Urological Association". www.auanet.org. Retrieved 6 October 2019.
- ^ "Dr. Dipen J Parekh, MD - Coral Gables, FL - Urologic Oncology, Urology". doctors.umiamihealth.org.
- ^ Sansom, Will (19 June 2009). "$2 million will advance doctor's high-tech work in San Antonio, the Rio Grande Valley". UT Health San Antonio.
- ^ Parekh, DJ; Reis, IM; Castle, EP; Gonzalgo, ML; Woods, ME; Svatek, RS; Weizer, AZ; Konety, BR; Tollefson, M; Krupski, TL; Smith, ND; Shabsigh, A; Barocas, DA; Quek, ML; Dash, A; Kibel, AS; Shemanski, L; Pruthi, RS; Montgomery, JS; Weight, CJ; Sharp, DS; Chang, SS; Cookson, MS; Gupta, GN; Gorbonos, A; Uchio, EM; Skinner, E; Venkatramani, V; Soodana-Prakash, N; Kendrick, K; Smith JA, Jr; Thompson, IM (23 June 2018). "Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial". Lancet. 391 (10139): 2525–2536. doi:10.1016/S0140-6736(18)30996-6. PMID 29976469. S2CID 49712431.
- ^ Health, William Wan closeWilliam WanNational correspondent covering. "Robotic surgery is no better than traditional surgery, bladder cancer study finds". Washington Post.
{{cite news}}:|first1=has generic name (help) - ^ Parekh, Dipen J.; Weinberg, Joel M.; Ercole, Barbara; Torkko, Kathleen C.; Hilton, William; Bennett, Michael; Devarajan, Prasad; Venkatachalam, Manjeri A. (14 February 2013). "Tolerance of the Human Kidney to Isolated Controlled Ischemia". Journal of the American Society of Nephrology. 24 (3): 506–517. doi:10.1681/ASN.2012080786. eISSN 1533-3450. ISSN 1046-6673. PMC 3582204. PMID 23411786.